NCT07225946 2026-04-14
KLK2-PASenger
Janssen Research & Development, LLC
Phase 3 Recruiting
Clinical Trials
6 trialsNCT03748641 2026-04-13
MAGNITUDE
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT06276465 2024-12-20
PEACE8
UNICANCER
Phase 3 Recruiting
NCT03016312 2024-08-09
IMbassador250
Hoffmann-La Roche
Phase 3 Completed
NCT04844749 2024-02-05
VERACITY
Veru Inc.
Phase 3 Terminated
NCT02057666 2021-04-23
TasQ003
Ipsen
Phase 3 Terminated